The conventional chemotherapeutic agents, used for cancer chemotherapy, have major
limitations including non-specificity, ubiquitous biodistribution, low concentration in tumor …

As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a
major research focus. These nanocarriers respond to specific stimulus signals (eg, pH …

In the last decade, considerable attention has been devoted to the use of biodegradable
polymeric materials as potential drug delivery carriers. However, bioavailability and drug …

Polymeric nanoparticles have been widely used as carriers of drugs and bioimaging agents
due to their excellent biocompatibility, biodegradability, and structural versatility. The …

The complexity of the tumor microenvironment presents significant challenges to cancer
therapy, while providing opportunities for targeted drug delivery. Using characteristic signals …

A bioresponsive polymeric nanocarrier for drug delivery is able to alter its physical and
physicochemical properties in response to a variety of biological signals and pathological …

Conventional chemotherapy for the treatment of cancer has limited specificity when
administered systemically and is often associated with toxicity issues. Enhanced …

The emergence and development of nanomedicine have alleviated problems existing in
traditional chemotherapy drugs, such as short lifetime, concomitant side effects, and weak …

Background: Rapid developments in the field of nanoparticles during the last decades have
led to its increased application in drug delivery approaches. The advantages of nano-based …

Stimuli-responsive nanocarriers have the potential to revolutionize cancer treatment by
allowing precise delivery of drugs to the site of disease. The use of polymeric nanocarriers …